Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 423 shares at $73.00 ($31K) on 2026-02-18, disclosed to the SEC on 2026-02-20.
Seasonal sale ($31k) by President & CEO — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2026-05-21 | $29K | — | Filing → |
| NKTR | SELL | 2025-11-25 | $240K | — | Filing → |
| NKTR | SELL | 2025-09-11 | $528K | — | Filing → |